Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery; a Randomized, Controlled, Non-inferiority Study
| Registry | NCT06326983 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: double, treatment |
| Enrollment | 62 (Actual) |
| Sponsor | Boston Children's Hospital (Other) |
| Conditions | Tonsillitis, Post-operative Nausea and Vomiting (PONV), Emergence Delirium, Opioid Analgesic Adverse Reaction, Anesthesia, Pain |
| Interventions | Dexmedetomidine, Acetaminophen, Ketorolac, Morphine (Drug) |
| Dates | start 2024-05-09, primary completion 2026-01-30, completion 2026-03-01, first posted 2024-03-25, last updated 2026-05-18 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Tonsillitis All trials for Post-operative Nausea and Vomiting (PONV) All trials of Dexmedetomidine All trials of Acetaminophen
This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic plan (dexmedetomidine, ketorolac and acetaminophen) for perioperative analgesia and recovery time in patients undergoing tonsillectomies and tonsillotomies at Boston Children's Hospital Waltham. Secondary measures include rescue opioids administered in post-anesthesia care unit (PACU), re-operation secondary to bleeding, emergence delirium, post-operative nausea and vomiting, intraoperative hemodynamics, intraoperative vasopressor administration, and length of procedure.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Opioid-Sparing Anesthetic Plan | Experimental | Drug: Dexmedetomidine; Drug: Acetaminophen; Drug: Ketorolac | For their tonsil surgery, subjects will receive Dexmedetomidine (1mcg/kg bolus given intravenously at induction of anesthesia) and Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia). Ketorolac 0.5mg/kg with a max dose of 30mg given intravenously at the end of surgery. No opioids will be given during the procedure. |
| Opioid Anesthetic Plan | Active comparator | Drug: Acetaminophen; Drug: Ketorolac; Drug: Morphine | For their tonsil surgery, subjects will receive Morphine (0.1mg/kg given intravenously at induction of anesthesia) and Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia). Ketorolac 0.5mg/kg with a max dose of 30mg intravenously at the end of surgery. |
Sex: All, ages: 3 Years to 17 Years
Inclusion Criteria: * American Society of Anesthesia classification status I-III * Ages 3 years to 17 years * Scheduled for tonsillectomy or tonsillotomy with or without adenoidectomy at Boston Children's Hospital Waltham Exclusion Criteria: * Patients not scheduled for primary tonsillectomy/tonsillotomy. * Patients with known coagulopathies * Patients with previous chronic pain syndromes * Patients with any condition/indication that would prevent them from being able to be randomized (i.e. allergy to one of the study medications)
| Facility | City | Country | Status |
|---|---|---|---|
| Boston Children's Hospital | Waltham, Massachusetts | United States |